ICD Code | ICD Description | Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Avg. LOS | 30 Day Readmission Rate (%) | Unplanned Readmission Rate (%) | Total Medicare Payments | Payment per Day | Payment per Hospitalization | Total Medicare Charges | Avg. Charges | In Hospital Mortality Rate (%) | Discharge to Home Rate (%) | SNF Discharge Rate (%) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3E03329 (Primary) | Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | |||||||||||||
3E033GC (Primary) | Introduction of Other Therapeutic Substance into Peripheral Vein, Percutaneous Approach | |||||||||||||
3E0337Z (Primary) | Introduction of Electrolytic and Water Balance Substance into Peripheral Vein, Percutaneous Approach | |||||||||||||
30233N1 (Primary) | Transfusion of Nonautologous Red Blood Cells into Peripheral Vein, Percutaneous Approach | |||||||||||||
3E0234Z (Primary) | Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | |||||||||||||
4A023N7 (Primary) | Measurement of Cardiac Sampling and Pressure, Left Heart, Percutaneous Approach | |||||||||||||
3E0F7GC (Primary) | Introduction of Other Therapeutic Substance into Respiratory Tract, Via Natural or Artificial Opening | |||||||||||||
5A1D70Z (Primary) | Performance of Urinary Filtration, Intermittent, Less than 6 Hours Per Day | |||||||||||||
3E013GC (Primary) | Introduction of Other Therapeutic Substance into Subcutaneous Tissue, Percutaneous Approach | |||||||||||||
4A12X4Z (Primary) | Monitoring of Cardiac Electrical Activity, External Approach | |||||||||||||
3E03305 (Primary) | Introduction of Other Antineoplastic into Peripheral Vein, Percutaneous Approach | |||||||||||||
4A023N8 (Primary) | Measurement of Cardiac Sampling and Pressure, Bilateral, Percutaneous Approach | |||||||||||||
02RF08Z (Primary) | Replacement of Aortic Valve with Zooplastic Tissue, Open Approach | |||||||||||||
02RF38Z (Primary) | Replacement of Aortic Valve with Zooplastic Tissue, Percutaneous Approach | |||||||||||||
02HV33Z (Primary) | Insertion of Infusion Device into Superior Vena Cava, Percutaneous Approach | |||||||||||||
5A09357 (Primary) | Assistance with Respiratory Ventilation, Less than 24 Consecutive Hours, Continuous Positive Airway Pressure | |||||||||||||
3E033NZ (Primary) | Introduction of Analgesics, Hypnotics, Sedatives into Peripheral Vein, Percutaneous Approach | |||||||||||||
3E0134Z (Primary) | Introduction of Serum, Toxoid and Vaccine into Subcutaneous Tissue, Percutaneous Approach | |||||||||||||
009U3ZX (Primary) | Drainage of Spinal Canal, Percutaneous Approach, Diagnostic | |||||||||||||
07DR3ZX (Primary) | Extraction of Iliac Bone Marrow, Percutaneous Approach, Diagnostic | |||||||||||||
0DJ08ZZ (Primary) | Inspection of Upper Intestinal Tract, Via Natural or Artificial Opening Endoscopic | |||||||||||||
4A10X4Z (Primary) | Monitoring of Central Nervous Electrical Activity, External Approach | |||||||||||||
0JH606Z (Primary) | Insertion of Pacemaker, Dual Chamber into Chest Subcutaneous Tissue and Fascia, Open Approach | |||||||||||||
0TY00Z0 (Primary) | Transplantation of Right Kidney, Allogeneic, Open Approach | |||||||||||||
0BH17EZ (Primary) | Insertion of Endotracheal Airway into Trachea, Via Natural or Artificial Opening | |||||||||||||
027034Z (Primary) | Dilation of Coronary Artery, One Artery with Drug-eluting Intraluminal Device, Percutaneous Approach | |||||||||||||
02583ZZ (Primary) | Destruction of Conduction Mechanism, Percutaneous Approach | |||||||||||||
F07Z9ZZ (Primary) | Gait Training/Functional Ambulation Treatment | |||||||||||||
F07Z9FZ (Primary) | Gait Training/Functional Ambulation Treatment using Assistive, Adaptive, Supportive or Protective Equipment | |||||||||||||
F07M2FZ (Primary) | Coordination/Dexterity Treatment of Musculoskeletal System - Whole Body using Assistive, Adaptive, Supportive or Protective Equipment | |||||||||||||
3E02340 (Primary) | Introduction of Influenza Vaccine into Muscle, Percutaneous Approach | |||||||||||||
5A1D60Z (Primary) | Performance of Urinary Filtration, Multiple | |||||||||||||
30233R1 (Primary) | Transfusion of Nonautologous Platelets into Peripheral Vein, Percutaneous Approach | |||||||||||||
0VT04ZZ (Primary) | Resection of Prostate, Percutaneous Endoscopic Approach | |||||||||||||
5A2204Z (Primary) | Restoration of Cardiac Rhythm, Single | |||||||||||||
0FT44ZZ (Primary) | Resection of Gallbladder, Percutaneous Endoscopic Approach | |||||||||||||
3E0333Z (Primary) | Introduction of Anti-inflammatory into Peripheral Vein, Percutaneous Approach | |||||||||||||
5A09457 (Primary) | Assistance with Respiratory Ventilation, 24-96 Consecutive Hours, Continuous Positive Airway Pressure | |||||||||||||
4B02XSZ (Primary) | Measurement of Cardiac Pacemaker, External Approach | |||||||||||||
5A1945Z (Primary) | Respiratory Ventilation, 24-96 Consecutive Hours | |||||||||||||
0W3P8ZZ (Primary) | Control Bleeding in Gastrointestinal Tract, Via Natural or Artificial Opening Endoscopic | |||||||||||||
GZ63ZZZ (Primary) | Other Counseling | |||||||||||||
5A1955Z (Primary) | Respiratory Ventilation, Greater than 96 Consecutive Hours | |||||||||||||
3E013VG (Primary) | Introduction of Insulin into Subcutaneous Tissue, Percutaneous Approach | |||||||||||||
0WUF0JZ (Primary) | Supplement Abdominal Wall with Synthetic Substitute, Open Approach | |||||||||||||
0W9G3ZZ (Primary) | Drainage of Peritoneal Cavity, Percutaneous Approach | |||||||||||||
3E04305 (Primary) | Introduction of Other Antineoplastic into Central Vein, Percutaneous Approach | |||||||||||||
GZB0ZZZ (Primary) | Electroconvulsive Therapy, Unilateral-Single Seizure | |||||||||||||
0DJD8ZZ (Primary) | Inspection of Lower Intestinal Tract, Via Natural or Artificial Opening Endoscopic | |||||||||||||
0F798DZ (Primary) | Dilation of Common Bile Duct with Intraluminal Device, Via Natural or Artificial Opening Endoscopic | |||||||||||||
02100Z9 (Primary) | Bypass Coronary Artery, One Artery from Left Internal Mammary, Open Approach | |||||||||||||
0D9670Z (Primary) | Drainage of Stomach with Drainage Device, Via Natural or Artificial Opening | |||||||||||||
01NB0ZZ (Primary) | Release Lumbar Nerve, Open Approach | |||||||||||||
0DB68ZX (Primary) | Excision of Stomach, Via Natural or Artificial Opening Endoscopic, Diagnostic | |||||||||||||
0T9B70Z (Primary) | Drainage of Bladder with Drainage Device, Via Natural or Artificial Opening | |||||||||||||
0DH63UZ (Primary) | Insertion of Feeding Device into Stomach, Percutaneous Approach | |||||||||||||
4A023N6 (Primary) | Measurement of Cardiac Sampling and Pressure, Right Heart, Percutaneous Approach | |||||||||||||
0W9G3ZX (Primary) | Drainage of Peritoneal Cavity, Percutaneous Approach, Diagnostic | |||||||||||||
F0732FZ (Primary) | Coordination/Dexterity Treatment of Neurological System - Whole Body using Assistive, Adaptive, Supportive or Protective Equipment | |||||||||||||
0TY10Z0 (Primary) | Transplantation of Left Kidney, Allogeneic, Open Approach | |||||||||||||
4B02XTZ (Primary) | Measurement of Cardiac Defibrillator, External Approach | |||||||||||||
0DB98ZX (Primary) | Excision of Duodenum, Via Natural or Artificial Opening Endoscopic, Diagnostic | |||||||||||||
5A1D00Z (Primary) | Performance of Urinary Filtration, Single | |||||||||||||
3E03317 (Primary) | Introduction of Other Thrombolytic into Peripheral Vein, Percutaneous Approach | |||||||||||||
02RF3JZ (Primary) | Replacement of Aortic Valve with Synthetic Substitute, Percutaneous Approach | |||||||||||||
0HQ0XZZ (Primary) | Repair Scalp Skin, External Approach | |||||||||||||
0QS704Z (Primary) | Reposition Left Upper Femur with Internal Fixation Device, Open Approach | |||||||||||||
0SRS0J9 (Primary) | Replacement of Left Hip Joint, Femoral Surface with Synthetic Substitute, Cemented, Open Approach | |||||||||||||
02RG08Z (Primary) | Replacement of Mitral Valve with Zooplastic Tissue, Open Approach | |||||||||||||
5A1935Z (Primary) | Respiratory Ventilation, Less than 24 Consecutive Hours | |||||||||||||
00B70ZZ (Primary) | Excision of Cerebral Hemisphere, Open Approach | |||||||||||||
02RX0JZ (Primary) | Replacement of Thoracic Aorta, Ascending/Arch with Synthetic Substitute, Open Approach | |||||||||||||
0B113F4 (Primary) | Bypass Trachea to Cutaneous with Tracheostomy Device, Percutaneous Approach | |||||||||||||
0DTN0ZZ (Primary) | Resection of Sigmoid Colon, Open Approach | |||||||||||||
00NY0ZZ (Primary) | Release Lumbar Spinal Cord, Open Approach | |||||||||||||
8E0ZXY6 (Primary) | Isolation | |||||||||||||
3E0D7GC (Primary) | Introduction of Other Therapeutic Substance into Mouth and Pharynx, Via Natural or Artificial Opening | |||||||||||||
B246ZZZ (Primary) | Ultrasonography of Right and Left Heart | |||||||||||||
0W9930Z (Primary) | Drainage of Right Pleural Cavity with Drainage Device, Percutaneous Approach | |||||||||||||
5A09557 (Primary) | Assistance with Respiratory Ventilation, Greater than 96 Consecutive Hours, Continuous Positive Airway Pressure | |||||||||||||
0DV44ZZ (Primary) | Restriction of Esophagogastric Junction, Percutaneous Endoscopic Approach | |||||||||||||
0CJS8ZZ (Primary) | Inspection of Larynx, Via Natural or Artificial Opening Endoscopic | |||||||||||||
0HQ1XZZ (Primary) | Repair Face Skin, External Approach | |||||||||||||
06H03DZ (Primary) | Insertion of Intraluminal Device into Inferior Vena Cava, Percutaneous Approach | |||||||||||||
0FC98ZZ (Primary) | Extirpation of Matter from Common Bile Duct, Via Natural or Artificial Opening Endoscopic | |||||||||||||
03LG3DZ (Primary) | Occlusion of Intracranial Artery with Intraluminal Device, Percutaneous Approach | |||||||||||||
0SRR0J9 (Primary) | Replacement of Right Hip Joint, Femoral Surface with Synthetic Substitute, Cemented, Open Approach | |||||||||||||
0W9G30Z (Primary) | Drainage of Peritoneal Cavity with Drainage Device, Percutaneous Approach | |||||||||||||
0W993ZZ (Primary) | Drainage of Right Pleural Cavity, Percutaneous Approach | |||||||||||||
0QS736Z (Primary) | Reposition Left Upper Femur with Intramedullary Internal Fixation Device, Percutaneous Approach | |||||||||||||
3E0330M (Primary) | Introduction of Monoclonal Antibody into Peripheral Vein, Percutaneous Approach | |||||||||||||
0QS606Z (Primary) | Reposition Right Upper Femur with Intramedullary Internal Fixation Device, Open Approach | |||||||||||||
F07M0ZZ (Primary) | Range of Motion and Joint Mobility Treatment of Musculoskeletal System - Whole Body | |||||||||||||
0QS604Z (Primary) | Reposition Right Upper Femur with Internal Fixation Device, Open Approach | |||||||||||||
0T778DZ (Primary) | Dilation of Left Ureter with Intraluminal Device, Via Natural or Artificial Opening Endoscopic | |||||||||||||
04V03DZ (Primary) | Restriction of Abdominal Aorta with Intraluminal Device, Percutaneous Approach | |||||||||||||
0W9B30Z (Primary) | Drainage of Left Pleural Cavity with Drainage Device, Percutaneous Approach | |||||||||||||
0DBB0ZZ (Primary) | Excision of Ileum, Open Approach | |||||||||||||
3E033VG (Primary) | Introduction of Insulin into Peripheral Vein, Percutaneous Approach | |||||||||||||
4A00X4Z (Primary) | Measurement of Central Nervous Electrical Activity, External Approach | |||||||||||||
0DTJ4ZZ (Primary) | Resection of Appendix, Percutaneous Endoscopic Approach |